Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 151-160 of 213 for melanoma

Edit search filters
  1. A Phase 1/2 Study Of CYT-0851 In B-Cell Malignancies And Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Melanoma Registry

    Jacksonville, FL

  3. Melanoma Care Barriers In United States Latinx Population

    Scottsdale/Phoenix, AZ

  4. A Study of Immune System Activity Cycles in Patients with Surgically Removed Early Stage Melanoma

    Rochester, MN

  5. A Study to Describe Patterns of Treatment, Demographics, Clinical Characteristics, and Overall Survival in Patients with Unresectable or Metastatic Melanoma

    Rochester, MN

  6. Detection of Mutant Circulating Tumor (CT)Dna in Uveal Melanoma With Development of a Droplet Digital Pcr (Ddpcr) Assay

    Rochester, MN

  7. MElanoma Research Lymph node prediction Implementation National_001 (MERLIN_001)

    Rochester, MN

  8. Innovative CAR-TIL immunotherapy against melanoma

    Jacksonville, FL

  9. Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

    Rochester, MN

  10. Circulating Tumor Nucleic Acids to Monitor Treatment Response in Metastatic Melanoma Patients

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer